Cargando…

Clinical signs of trachoma and laboratory evidence of ocular Chlamydia trachomatis infection in a remote Queensland community: a serial cross‐sectional study

OBJECTIVES: To compare the findings of standard clinical assessments and of complementary clinical and laboratory methods for determining whether community‐wide treatment for trachoma is warranted in a remote Queensland community. DESIGN: Three cross‐sectional screening surveys, 2019–2021, complemen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lynch, Kathleen D, Morotti, Wendy, Brian, Garry, Ketchup, Lenore, Kingston, Kozue, Starr, Mitchell, Ware, Robert S, Everill, Beth, Asgar, Nazihah, O'Keefe, Anne, Whop, Lisa J, Kaldor, John M, Lambert, Stephen B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research and Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827872/ https://www.ncbi.nlm.nih.gov/pubmed/36180097 http://dx.doi.org/10.5694/mja2.51735

Ejemplares similares

Natural Products for the Treatment of Trachoma and Chlamydia trachomatis
por: Potroz, Michael G., et al.
Publicado: (2015)

Trachoma: Protective and Pathogenic Ocular Immune Responses to Chlamydia trachomatis
por: Hu, Victor H., et al.
Publicado: (2013)

Chlamydia trachomatis ompA Variants in Trachoma: What Do They Tell Us?
por: Andreasen, Aura A., et al.
Publicado: (2008)

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
por: Hong, Kevin Cyrus, et al.
Publicado: (2009)

Conjunctival transcriptome profiling of Solomon Islanders with active trachoma in the absence of Chlamydia trachomatis infection
por: Vasileva, Hristina, et al.
Publicado: (2018)

Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of Fiji
por: Macleod, Colin K., et al.
Publicado: (2016)

The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children
por: West, Sheila K., et al.
Publicado: (2020)

Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020?
por: Harding-Esch, Emma M., et al.
Publicado: (2009)

Chlamydia trachomatis from Australian Aboriginal people with trachoma are polyphyletic composed of multiple distinctive lineages
por: Andersson, Patiyan, et al.
Publicado: (2016)

Trachoma, Anti-Pgp3 Serology, and Ocular Chlamydia trachomatis Infection in Papua New Guinea
por: Macleod, Colin K, et al.
Publicado: (2020)

Genomics of Ocular Chlamydia trachomatis After 5 Years of SAFE Interventions for Trachoma in Amhara, Ethiopia
por: Pickering, Harry, et al.
Publicado: (2020)

Risk Factors for Active Trachoma and Ocular Chlamydia trachomatis Infection in Treatment-Naïve Trachoma-Hyperendemic Communities of the Bijagós Archipelago, Guinea Bissau
por: Last, Anna R., et al.
Publicado: (2014)

The Easiest Children to Reach Are Most Likely to Be Infected with Ocular Chlamydia trachomatis in Trachoma Endemic Areas of Niger
por: Amza, Abdou, et al.
Publicado: (2013)

The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment
por: Ramadhani, Athumani M., et al.
Publicado: (2016)

Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area
por: West, Sheila K., et al.
Publicado: (2018)

Global survey of mRNA levels and decay rates of Chlamydia trachomatis trachoma and lymphogranuloma venereum biovars
por: Ferreira, Rita, et al.
Publicado: (2017)

Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands
por: Marks, M, et al.
Publicado: (2016)

Viability PCR shows that non-ocular surfaces could contribute to transmission of Chlamydia trachomatis infection in trachoma
por: Versteeg, Bart, et al.
Publicado: (2020)

The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma
por: Gwyn, Sarah, et al.
Publicado: (2021)

Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: A Five-Year Longitudinal Study of Trachoma Endemic Communities
por: Burton, Matthew J., et al.
Publicado: (2010)

Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Naïve Trachoma-Endemic Region of the Solomon Islands
por: Butcher, Robert M. R., et al.
Publicado: (2016)

Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati
por: Cama, Anaseini, et al.
Publicado: (2017)

Detecting extra-ocular Chlamydia trachomatis in a trachoma-endemic community in Ethiopia: Identifying potential routes of transmission
por: Last, Anna, et al.
Publicado: (2020)

Population-Based Prevalence of Ocular Chlamydia trachomatis Infection among Infants in the Trachoma Endemic Amhara Region, Ethiopia
por: Nash, Scott D., et al.
Publicado: (2022)

Prevalence of Ocular Chlamydia trachomatis Infection in Amhara Region, Ethiopia, after 8 Years of Trachoma Control Interventions
por: Nash, Scott D., et al.
Publicado: (2023)

Field Evaluation of the Cepheid GeneXpert Chlamydia trachomatis Assay for Detection of Infection in a Trachoma Endemic Community in Tanzania
por: Jenson, Alexander, et al.
Publicado: (2013)

Correction: Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Naïve Trachoma-Endemic Region of the Solomon Islands
por: Butcher, Robert M. R., et al.
Publicado: (2016)

Clinical signs of trachoma are prevalent among Solomon Islanders who have no persistent markers of prior infection with Chlamydia trachomatis
por: Butcher, Robert, et al.
Publicado: (2018)

Spatial clustering of high load ocular Chlamydia trachomatis infection in trachoma: a cross-sectional population-based study
por: Last, Anna, et al.
Publicado: (2017)

DjinniChip: evaluation of a novel molecular rapid diagnostic device for the detection of Chlamydia trachomatis in trachoma-endemic areas
por: Derrick, Tamsyn R., et al.
Publicado: (2020)

Population-Based Prevalence of Chlamydia trachomatis Infection and Antibodies in Four Districts with Varying Levels of Trachoma Endemicity in Amhara, Ethiopia
por: Nash, Scott D., et al.
Publicado: (2021)

Concordance of ompA types in children re-infected with ocular Chlamydia trachomatis following mass azithromycin treatment for trachoma
por: Mosenia, Arman, et al.
Publicado: (2022)

Chlamydia Trachomatis Tonsillopharyngitis
por: Öztürk, Özmen, et al.
Publicado: (2012)

Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community
por: Ramadhani, Athumani M., et al.
Publicado: (2019)

Conjunctival FOXP3 Expression in Trachoma: Do Regulatory T Cells Have a Role in Human Ocular Chlamydia trachomatis Infection?
por: Faal, Nkoyo, et al.
Publicado: (2006)

Population-based analysis of ocular Chlamydia trachomatis in trachoma-endemic West African communities identifies genomic markers of disease severity
por: Last, A. R., et al.
Publicado: (2018)

Expression and structure of the Chlamydia trachomatis DksA ortholog
por: Mandel, Cameron, et al.
Publicado: (2022)

Consensus by Chinese Expert Panel on Chlamydia trachomatis-Resistant and Chlamydia trachomatis-Persistent Infection
por: Qi, Man-Li, et al.
Publicado: (2017)

Chlamydia trachomatis: Management in Pregnancy
por: Allaire, Alex, et al.
Publicado: (1995)

Screening on urogenital Chlamydia trachomatis
por: de Carvalho Gomes, Helena, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_aq7tmu3cb5rrjdignu4medrc4g